Human in vivo study reveals placenta-derived proteins in preeclampsia, highlighting their potential as clinical biomarkers.
Using a unique in vivo sampling method, we identified placenta-derived proteins in preeclampsia, several of which showed promising biomarker potential.
No takes yet. Share an insight, caveat, or question.
Westerberg et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: